Home

News

Martin Howe KC speaks at Cayman Chancery Bar Association Conference25 November 2024Martin Howe KC took part in the Chancery Bar Association’s Cayman Islands Conference on 7th-8th November 2024 at the Grand Cayman Marriott. He gave a talk on “Intellectual Property in the Cayman Islands and beyond” (lecture slides), which covered Cayman law on copyright, confidential information, patents, trade marks and designs, interpretation by reference to UK […]
Thom Browne Inc v adidas AG [2024] EWHC 2990 (Ch)22 November 2024Charlotte May KC and Maxwell Keay appeared before the High Court for the Defendants (“adidas”) in the Claimants’ (“Thom Browne”) action seeking to invalidate a portfolio of sixteen of adidas’ registered trade marks, all of which related to “Three Stripes” as position marks. adidas counterclaimed for trade mark infringement under sections 10(2) and 10(3) of […]
Iona Berkeley speaks at CITMA Seminar for litigators21 November 2024Iona Berkeley took part in the Chartered Institute of Trade Mark Attorneys Conference on 21 November 2024. She gave a talk on Trial Advocacy: insights into preparing for trials in the IPEC and the High Court.
iSmart Developments v Currentbody.com [2024] EWHC 2889 (IPEC)15 November 2024James Abrahams KC and Henry Edwards appeared for the successful Defendant in the Claimants’ application in each of two related actions to strike out allegations of breach of contract and misuse of confidential information, and alternatively for summary judgment. HHJ Hacon dismissed the applications and held that the Defendant’s case based on alleged breach of […]
Extreme Networks Ltd v Extreme E Ltd [2024] EWCA Civ 138614 November 2024Ashton Chantrielle appeared before the Court of Appeal for the Applicant/Respondent (“Extreme E”) in this second appeal from the UKIPO relating to Extreme E’s trade mark registration for services in Class 41. One of the core issues on appeal was the interpretation of “booking of seats for shows” in Extreme E’s trade mark and its […]
SkyKick UK Ltd v Sky Ltd [2024] UKSC 3613 November 2024Adrian Speck KC appeared for the successful Appellants (“SkyKick”) in the proceedings issued by the Respondents (“Sky”) alleging infringement of several SKY marks, and passing off, by SkyKick’s use of SKYKICK for email migration and cloud storage services. In this landmark decision, the Supreme Court held that the registration of a trade mark can be […]
Kieran Corrigan v Timol [2024] EWCA Civ 123318 October 2024Jonathan Hill appeared for the Appellant, Kieran Corrigan & Co Limited (“KCL”) in its appeal against the decision of Jonathan Hilliard KC (sitting as a Deputy High Court Judge) (“the Judge”) to dismiss claims for breach of confidence against the Respondent (“Mr. Timol”). The claims related to the alleged misuse by a company of which […]
Sandoz AG v Biogen MA Inc [2024] EWHC 2567 (Pat)11 October 2024Michael Tappin KC appeared for the Claimants (Sandoz) and Justin Turner KC appeared for the Defendant (Biogen). Sandoz sought revocation of Biogen’s patent and an Arrow declaration, while Biogen counterclaimed for infringement. Biogen’s patent in suit, EP 967, related to a method for assessing the risk of progressive multifocal leukoencephalopathy (PML) in multiple sclerosis (MS) […]
BioNTech SE v CureVac SE [2024] EWHC 2538 (Pat)8 October 2024Michael Tappin KC and Michael Conway appeared for the successful Claimant (BioNTech) in this action seeking revocation of two of the Defendant’s (CureVac) patents. The patents, EP 668 and EP 755 were divisionals from a common earlier application and their descriptions were materially identical. They claimed artificial mRNA molecules in which the poly(A) tail was […]
Accord Healthcare v Regents of the University of California [2024] EWHC 2524 (Pat)8 October 2024Justin Turner KC appeared for the Claimants and Andrew Lykiardopoulos KC appeared for the Defendants in this action to revoke the patent and invalidate the SPC owned by the First Defendant and exclusively licensed to the Second Defendant. The patent in suit, EP 196, claimed the compound enzalutamide for the treatment of hormone refractory prostate […]